KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
10.18.17 - Novomer to open new innovation center in Rochester, NY...more
09.26.17 - Chobani Incubator Program selects Grainful to be a part of the Fall 2017 class...more
09.26.17 - AI-Driven discovery of novel predictors of Parkinson's disease progression by GNS Healthcare appears in Lancet Neurology ...more
06.19.17 - GNS Healthcare announces collaboration with Genentech for development of novel cancer therapies ...more
06.07.17 - Grainful closes $3.3million round of financing as Americans embrace savory oats...more
03.03.17 - Tukek Holding leads new biorefinery complex in Adana that will incorporate Novomer technology ...more
02.27.17 - Supercritical Carbon Dioxide–Based Sterilization of Decellularized Heart Valves...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319